Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Arcadia Biosciences (RKDA) over the last 12 years, with Q3 2025 value amounting to -$278000.0.

  • Arcadia Biosciences' Net Cash Flow rose 8227.04% to -$278000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.8 million, marking a year-over-year increase of 5792.55%. This contributed to the annual value of -$2.2 million for FY2024, which is 8408.58% up from last year.
  • Per Arcadia Biosciences' latest filing, its Net Cash Flow stood at -$278000.0 for Q3 2025, which was up 8227.04% from -$1.8 million recorded in Q2 2025.
  • Arcadia Biosciences' Net Cash Flow's 5-year high stood at $16.8 million during Q1 2021, with a 5-year trough of -$9.5 million in Q2 2023.
  • Over the past 5 years, Arcadia Biosciences' median Net Cash Flow value was -$1.8 million (recorded in 2025), while the average stood at -$788473.7.
  • Its Net Cash Flow has fluctuated over the past 5 years, first soared by 26885.43% in 2021, then plummeted by 29346.8% in 2023.
  • Over the past 5 years, Arcadia Biosciences' Net Cash Flow (Quarter) stood at -$6.9 million in 2021, then skyrocketed by 69.49% to -$2.1 million in 2022, then crashed by 95.38% to -$4.1 million in 2023, then surged by 108.12% to $333000.0 in 2024, then crashed by 183.48% to -$278000.0 in 2025.
  • Its Net Cash Flow was -$278000.0 in Q3 2025, compared to -$1.8 million in Q2 2025 and -$1.1 million in Q1 2025.